Holdings
Opaleye Management Inc.
As of Sep 30, 2026, Opaleye Management Inc. reported 53 positions worth US$776M. Largest: Eton Pharmaceuticals, Inc., Disc Medicine, Inc. and Harrow, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | 2.44M | US$126M | −420K | Sep 30, 2026 |
| Disc Medicine, Inc. | 1.09M | US$71.7M | +240K | Sep 30, 2026 |
| Harrow, Inc. | 2.1M | US$64.8M | −295K | Sep 30, 2026 |
| Liquidia Corporation | 2.11M | US$63.8M | −338K | Sep 30, 2026 |
| MeiraGTx Holdings plc | 3.6M | US$39.6M | +50,000 | Sep 30, 2026 |
| TG Therapeutics, Inc. | 557K | US$31.1M | +22,000 | Sep 30, 2026 |
| Alpha Cognition Inc. | 3.3M | US$29.7M | +408K | Sep 30, 2026 |
| Immix Biopharma, Inc. | 2.83M | US$29.4M | +480K | Sep 30, 2026 |
| Crescent Biopharma, Inc. | 1.65M | US$24M | +327K | Sep 30, 2026 |
| Verastem, Inc. | 2.75M | US$22.2M | +953K | Sep 30, 2026 |